Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$493.64 USD
-6.24 (-1.25%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $494.68 +1.04 (0.21%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
02/03/2025
Time: -- |
12/2024 | $4.19 | -1.93% |
Earnings Summary
For their last quarter, Vertex Pharmaceuticals (VRTX) reported earnings of $4.38 per share, beating the Zacks Consensus Estimate of $4.13 per share. This reflects a positive earnings surprise of 6.05%. Look out for VRTX's next earnings release expected on February 03, 2025. For the next earning release, we expect the company to report earnings of $4.19 per share, reflecting a year-over-year decrease of .24%.
Earnings History
Price & Consensus
Zacks News for VRTX
Vertex Pharmaceuticals (VRTX) Crossed Above the 50-Day Moving Average: What That Means for Investors
VRTX: What are Zacks experts saying now?
Zacks Private Portfolio Services